Investor Relations

Corporate Profile

PLx Pharma Inc. (Nasdaq: PLXP), is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform designed to provide more effective and safer products. The PLxGuard™  drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. PLx Pharma believes this platform has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with certain drugs.

Stock Quote

Exchange
Volume
Today's Open
Previous Close

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stock Chart

Recent News

Date Title
09/09/21
Summary TogglePLx Pharma Inc. to Present at Upcoming Virtual Healthcare Industry Conferences
SPARTA, N.J. , Sept. 09, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products, with its lead
08/26/21
Summary TogglePLx Pharma Inc.’s VAZALORE™ Now on Shelves; National Media Campaign Launches Today
-- Executing broad reach television advertising to support the launch of VAZALORE -- -- Media campaign reach matches extensive distribution at retailers -- SPARTA, N.J. , Aug. 26, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company
08/06/21
Summary TogglePLx Pharma Inc. Reports Second Quarter 2021 Results and Provides Business Update
--Walmart, Walgreens, Rite Aid, CVS and many other retailers placing VAZALORE on shelves later this month-- --VAZALORE launch inventory manufactured and currently shipping to retailers across the country-- SPARTA, N.J. , Aug. 06, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc.

Upcoming Events